| DC Field | Value | Language |
|---|
| dc.contributor.author | Berezhnova, T. A. | - |
| dc.contributor.author | Shishkina, V. V. | - |
| dc.contributor.author | Esaulenko, D. I. | - |
| dc.contributor.author | Lunyova, Y. A. | - |
| dc.contributor.author | Goryushkina, Y. S. | - |
| dc.date.accessioned | 2023-10-03T09:13:53Z | - |
| dc.date.available | 2023-10-03T09:13:53Z | - |
| dc.date.issued | 2023 | - |
| dc.identifier.citation | Combined use of pulse therapy and molecular hydrogen in rats with experimental rheumatoid arthritis: Clinical and histological evaluation of therapeutic effectiveness / T.A. Berezhnova [et al.] // Research Results in Pharmacology. - 2023. - Vol.9, №2.-P. 27-35. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/56824 | - |
| dc.description.abstract | The search for new therapeutic options for rheumatoid arthritis is expanded due to major antioxidant substances that can reduce duration of treatment, while ensuring positive dynamics of the course of the disease | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | immunohistochemical analysis | ru |
| dc.subject | mast cells | ru |
| dc.subject | molecular hydrogen | ru |
| dc.subject | pulse therapy | ru |
| dc.subject | rheumatoid arthritis | ru |
| dc.subject | CD68 | ru |
| dc.subject | CD163 | ru |
| dc.subject | TGF-β1 | ru |
| dc.title | Combined use of pulse therapy and molecular hydrogen in rats with experimental rheumatoid arthritis: Clinical and histological evaluation of therapeutic effectiveness | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 9, № 2
|
